| 名稱 | FLT3-ITD D835del/BaF3 |
| 型號(hào) | CBP73241 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FLT3-ITD [D835del]/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 【連載-企業(yè)參考品】乳腺癌的PCR和NGS參考品的選擇
- NIPT標(biāo)準(zhǔn)品-助力無創(chuàng)產(chǎn)前檢測(cè)
- PLoS ONE：科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- 一個(gè)蛋白竟可同時(shí)影響乳腺癌和淋巴癌的形成與擴(kuò)散
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- FLT3標(biāo)準(zhǔn)品簡(jiǎn)介
- IL4藥物細(xì)胞篩選模型
- 細(xì)胞株的表達(dá)量越高越好嗎？
- NGS檢測(cè)血液腫瘤基因
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73241FLT3-ITD D835del/BaF3
- 詳細(xì)內(nèi)容
| CBP73241 | |
| I. Introduction | |
Cell Line Name： | FLT3-ITD [D835del]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
FLT3, receptor-type tyrosine-protein kinase FLT3, activates Akt, Ras, and Erk pathways to regulate differentiation, proliferation, and survival of hematopoietic progenitor cells (PMID: 29316714, PMID: 28538663). Activating mutations of FLT3 are common in hematologic tumors (PMID: 19467916) and the internal tandem duplication (ITD) mutation is commonly observed in acute myeloid leukemia (PMID: 30181385). | |
| III. Representative Data | |
1.FLT3-ITD [D835del]/BaF3
| |
2. Anti-proliferation assay | |
Figure . Anti-proliferation assay of three reference compounds on the FLT3-ITD [D835del]/BaF3 Stable Cell Line. | |
會(huì)員_a.png)